- Home
- XHG vs VNRX Comparison
XHG vs VNRX Comparison
Compare XHG & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XHG
- VNRX
- Stock Information
- Founded
- XHG 2012
- VNRX N/A
- Country
- XHG China
- VNRX United States
- Employees
- XHG 38
- VNRX N/A
- Industry
- XHG
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- XHG
- VNRX Health Care
- Exchange
- XHG NYSE
- VNRX Nasdaq
- Market Cap
- XHG 66.8M
- VNRX 52.4M
- IPO Year
- XHG 2019
- VNRX N/A
- Fundamental
- Price
- XHG $1.40
- VNRX $0.66
- Analyst Decision
- XHG
- VNRX Strong Buy
- Analyst Count
- XHG 0
- VNRX 5
- Target Price
- XHG N/A
- VNRX $3.88
- AVG Volume (30 Days)
- XHG 123.2K
- VNRX 318.9K
- Earning Date
- XHG 07-18-2025
- VNRX 08-13-2025
- Dividend Yield
- XHG N/A
- VNRX N/A
- EPS Growth
- XHG N/A
- VNRX N/A
- EPS
- XHG N/A
- VNRX N/A
- Revenue
- XHG $41,110,414.00
- VNRX $1,308,361.00
- Revenue This Year
- XHG N/A
- VNRX $563.72
- Revenue Next Year
- XHG N/A
- VNRX $160.43
- P/E Ratio
- XHG N/A
- VNRX N/A
- Revenue Growth
- XHG N/A
- VNRX 64.16
- 52 Week Low
- XHG $1.16
- VNRX $0.40
- 52 Week High
- XHG $1,200.00
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- XHG 37.77
- VNRX 47.94
- Support Level
- XHG $1.26
- VNRX $0.62
- Resistance Level
- XHG $1.37
- VNRX $0.76
- Average True Range (ATR)
- XHG 0.12
- VNRX 0.08
- MACD
- XHG 0.08
- VNRX -0.02
- Stochastic Oscillator
- XHG 42.02
- VNRX 12.47
About XHG XCHANGE TEC.INC SPON ADS EACH REP 600000 SHS(POST SPLIT)
XChange Tec Inc, through its subsidiaries operates in insurance agency and insurance technology business. The company specialized in distributing automobile insurance policies at the earlier stage of business and subsequently expanded insurance product portfolio to include other types of insurance including life, health, group accident and other property related insurances. A maximum of the insurance purchased through platform and agency services is of automobile insurance.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.